| Income Statement | 2025-09-30 | 2025-06-30 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|
| Comprehensive loss | -2,513 | -2,622 | -29,203 | -189 |
| Basic (in shares) | 14,419,000 | 14,364,000 | 14,768,000 | 14,839,000 |
| Diluted (in shares) | 14,419,000 | 14,517,000 | 14,768,000 | 14,839,000 |
| Us-gaap_earningspersharebasic | -0.16 | -0.28 | -2.03 | -0.01 |
| Us-gaap_earningspersharediluted | -0.16 | -0.28 | -2.03 | -0.01 |
Anika Therapeutics, Inc. (ANIK)
Anika Therapeutics, Inc. (ANIK)